nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—IGF1 pathway—NCK2—glaucoma	0.0324	0.0953	CbGpPWpGaD
Tiludronate—Developmental delay—Pilocarpine—glaucoma	0.0249	0.0395	CcSEcCtD
Tiludronate—Congenital anomaly—Pilocarpine—glaucoma	0.0249	0.0395	CcSEcCtD
Tiludronate—PTPN1—Insulin Pathway—NCK2—glaucoma	0.0234	0.0689	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—TXN—glaucoma	0.0183	0.0539	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RPTOR—glaucoma	0.0153	0.0449	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—NCK2—glaucoma	0.0148	0.0435	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—glaucoma	0.0136	0.0398	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—FN1—glaucoma	0.0119	0.0349	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—RPTOR—glaucoma	0.0114	0.0333	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—BAD—glaucoma	0.0108	0.0317	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—NCK2—glaucoma	0.0104	0.0304	CbGpPWpGaD
Tiludronate—Pain—Dipivefrin—glaucoma	0.0102	0.0162	CcSEcCtD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—glaucoma	0.0101	0.0297	CbGpPWpGaD
Tiludronate—Rhinitis—Metipranolol—glaucoma	0.00947	0.015	CcSEcCtD
Tiludronate—PTPN1—eye—glaucoma	0.00939	0.317	CbGeAlD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.00923	0.0271	CbGpPWpGaD
Tiludronate—PTPN1—connective tissue—glaucoma	0.00904	0.305	CbGeAlD
Tiludronate—Pain—Echothiophate—glaucoma	0.00856	0.0136	CcSEcCtD
Tiludronate—Nausea—Physostigmine—glaucoma	0.00834	0.0132	CcSEcCtD
Tiludronate—PTPN1—Insulin Pathway—CAV1—glaucoma	0.00829	0.0243	CbGpPWpGaD
Tiludronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—glaucoma	0.00784	0.023	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—CAV1—glaucoma	0.00738	0.0217	CbGpPWpGaD
Tiludronate—Influenza like illness—Clonidine—glaucoma	0.00734	0.0116	CcSEcCtD
Tiludronate—Myalgia—Metipranolol—glaucoma	0.007	0.0111	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PEX19—glaucoma	0.00695	0.0204	CbGpPWpGaD
Tiludronate—Back pain—Latanoprost—glaucoma	0.00646	0.0103	CcSEcCtD
Tiludronate—Vertigo—Methazolamide—glaucoma	0.0062	0.00984	CcSEcCtD
Tiludronate—Rhinitis—Apraclonidine—glaucoma	0.00615	0.00976	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Metipranolol—glaucoma	0.00612	0.00971	CcSEcCtD
Tiludronate—Rhinitis—Bimatoprost—glaucoma	0.00596	0.00946	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—BCL2L1—glaucoma	0.00572	0.0168	CbGpPWpGaD
Tiludronate—Arthralgia—Latanoprost—glaucoma	0.00569	0.00903	CcSEcCtD
Tiludronate—ATP6V1A—eye—glaucoma	0.00562	0.19	CbGeAlD
Tiludronate—ATP6V1A—retina—glaucoma	0.00557	0.188	CbGeAlD
Tiludronate—Dyspepsia—Diclofenamide—glaucoma	0.00538	0.00855	CcSEcCtD
Tiludronate—Rhinitis—Brimonidine—glaucoma	0.00528	0.00838	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—glaucoma	0.00527	0.0155	CbGpPWpGaD
Tiludronate—Dyspepsia—Carbachol—glaucoma	0.00525	0.00834	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—BAD—glaucoma	0.00518	0.0152	CbGpPWpGaD
Tiludronate—Pain—Carbachol—glaucoma	0.0051	0.0081	CcSEcCtD
Tiludronate—Pain—Levobunolol—glaucoma	0.00503	0.00798	CcSEcCtD
Tiludronate—Rhinitis—Travoprost—glaucoma	0.00502	0.00797	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00497	0.00788	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—VEGFA—glaucoma	0.00496	0.0146	CbGpPWpGaD
Tiludronate—Dyspepsia—Methazolamide—glaucoma	0.00496	0.00787	CcSEcCtD
Tiludronate—Rhinitis—Brinzolamide—glaucoma	0.00496	0.00787	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—BAD—glaucoma	0.00492	0.0144	CbGpPWpGaD
Tiludronate—Asthenia—Metipranolol—glaucoma	0.00482	0.00765	CcSEcCtD
Tiludronate—Rhinitis—Pilocarpine—glaucoma	0.00476	0.00756	CcSEcCtD
Tiludronate—Abdominal pain—Carbachol—glaucoma	0.00472	0.00749	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00469	0.0138	CbGpPWpGaD
Tiludronate—Pain—Latanoprost—glaucoma	0.00466	0.0074	CcSEcCtD
Tiludronate—Vertigo—Bimatoprost—glaucoma	0.00465	0.00738	CcSEcCtD
Tiludronate—Myalgia—Apraclonidine—glaucoma	0.00455	0.00722	CcSEcCtD
Tiludronate—Asthenia—Carteolol—glaucoma	0.00446	0.00708	CcSEcCtD
Tiludronate—Dizziness—Metipranolol—glaucoma	0.00444	0.00705	CcSEcCtD
Tiludronate—Asthenia—Diclofenamide—glaucoma	0.00439	0.00697	CcSEcCtD
Tiludronate—Back pain—Dorzolamide—glaucoma	0.00423	0.00672	CcSEcCtD
Tiludronate—Asthenia—Levobunolol—glaucoma	0.00422	0.00669	CcSEcCtD
Tiludronate—Back pain—Travoprost—glaucoma	0.00422	0.00669	CcSEcCtD
Tiludronate—Headache—Metipranolol—glaucoma	0.00421	0.00668	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00419	0.0123	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—NOS3—glaucoma	0.00416	0.0122	CbGpPWpGaD
Tiludronate—Back pain—Brinzolamide—glaucoma	0.00416	0.00661	CcSEcCtD
Tiludronate—Dizziness—Carteolol—glaucoma	0.00411	0.00653	CcSEcCtD
Tiludronate—Diarrhoea—Carbachol—glaucoma	0.00408	0.00648	CcSEcCtD
Tiludronate—Dizziness—Diclofenamide—glaucoma	0.00404	0.00642	CcSEcCtD
Tiludronate—Asthenia—Methazolamide—glaucoma	0.00404	0.00641	CcSEcCtD
Tiludronate—Diarrhoea—Levobunolol—glaucoma	0.00402	0.00638	CcSEcCtD
Tiludronate—Back pain—Pilocarpine—glaucoma	0.004	0.00635	CcSEcCtD
Tiludronate—Nausea—Metipranolol—glaucoma	0.00399	0.00633	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00397	0.0063	CcSEcCtD
Tiludronate—Dizziness—Carbachol—glaucoma	0.00395	0.00627	CcSEcCtD
Tiludronate—Vertigo—Dorzolamide—glaucoma	0.00393	0.00624	CcSEcCtD
Tiludronate—Vertigo—Travoprost—glaucoma	0.00392	0.00622	CcSEcCtD
Tiludronate—Myalgia—Brimonidine—glaucoma	0.0039	0.00619	CcSEcCtD
Tiludronate—Arthralgia—Brimonidine—glaucoma	0.0039	0.00619	CcSEcCtD
Tiludronate—Headache—Carteolol—glaucoma	0.0039	0.00619	CcSEcCtD
Tiludronate—Dizziness—Levobunolol—glaucoma	0.00389	0.00617	CcSEcCtD
Tiludronate—Vertigo—Brinzolamide—glaucoma	0.00387	0.00614	CcSEcCtD
Tiludronate—Diarrhoea—Methazolamide—glaucoma	0.00385	0.00612	CcSEcCtD
Tiludronate—Headache—Diclofenamide—glaucoma	0.00383	0.00608	CcSEcCtD
Tiludronate—Rhinitis—Clonidine—glaucoma	0.0038	0.00604	CcSEcCtD
Tiludronate—Headache—Carbachol—glaucoma	0.00374	0.00594	CcSEcCtD
Tiludronate—Arthralgia—Dorzolamide—glaucoma	0.00373	0.00592	CcSEcCtD
Tiludronate—Pain—Apraclonidine—glaucoma	0.00373	0.00592	CcSEcCtD
Tiludronate—Dyspepsia—Bimatoprost—glaucoma	0.00372	0.0059	CcSEcCtD
Tiludronate—Myalgia—Travoprost—glaucoma	0.00371	0.00589	CcSEcCtD
Tiludronate—Arthralgia—Travoprost—glaucoma	0.00371	0.00589	CcSEcCtD
Tiludronate—Nausea—Carteolol—glaucoma	0.00369	0.00587	CcSEcCtD
Tiludronate—Headache—Levobunolol—glaucoma	0.00368	0.00585	CcSEcCtD
Tiludronate—Myalgia—Brinzolamide—glaucoma	0.00366	0.00582	CcSEcCtD
Tiludronate—Arthralgia—Brinzolamide—glaucoma	0.00366	0.00582	CcSEcCtD
Tiludronate—Nausea—Diclofenamide—glaucoma	0.00363	0.00577	CcSEcCtD
Tiludronate—Pain—Bimatoprost—glaucoma	0.00361	0.00574	CcSEcCtD
Tiludronate—Dizziness—Latanoprost—glaucoma	0.0036	0.00572	CcSEcCtD
Tiludronate—Gastrointestinal pain—Apraclonidine—glaucoma	0.00356	0.00566	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.00356	0.0104	CbGpPWpGaD
Tiludronate—Nausea—Carbachol—glaucoma	0.00355	0.00563	CcSEcCtD
Tiludronate—Headache—Methazolamide—glaucoma	0.00353	0.0056	CcSEcCtD
Tiludronate—Myalgia—Pilocarpine—glaucoma	0.00352	0.00559	CcSEcCtD
Tiludronate—Arthralgia—Pilocarpine—glaucoma	0.00352	0.00559	CcSEcCtD
Tiludronate—Nausea—Levobunolol—glaucoma	0.00349	0.00554	CcSEcCtD
Tiludronate—ATP6V1A—Disease—LRP12—glaucoma	0.00346	0.0102	CbGpPWpGaD
Tiludronate—Abdominal pain—Apraclonidine—glaucoma	0.00344	0.00547	CcSEcCtD
Tiludronate—Dyspepsia—Acetazolamide—glaucoma	0.00343	0.00545	CcSEcCtD
Tiludronate—Headache—Latanoprost—glaucoma	0.00341	0.00542	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00341	0.00541	CcSEcCtD
Tiludronate—Nausea—Methazolamide—glaucoma	0.00334	0.00531	CcSEcCtD
Tiludronate—Rhinitis—Betaxolol—glaucoma	0.00331	0.00526	CcSEcCtD
Tiludronate—Dyspepsia—Brimonidine—glaucoma	0.00329	0.00523	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00325	0.00517	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Travoprost—glaucoma	0.00324	0.00514	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.0032	0.00508	CcSEcCtD
Tiludronate—Pain—Brimonidine—glaucoma	0.0032	0.00508	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.00317	0.00932	CbGpPWpGaD
Tiludronate—Dyspepsia—Dorzolamide—glaucoma	0.00314	0.00499	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00313	0.0092	CbGpPWpGaD
Tiludronate—Dyspepsia—Travoprost—glaucoma	0.00313	0.00497	CcSEcCtD
Tiludronate—Asthenia—Apraclonidine—glaucoma	0.00313	0.00496	CcSEcCtD
Tiludronate—Dyspepsia—Brinzolamide—glaucoma	0.00309	0.00491	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00308	0.00488	CcSEcCtD
Tiludronate—Pain—Dorzolamide—glaucoma	0.00305	0.00485	CcSEcCtD
Tiludronate—Pain—Travoprost—glaucoma	0.00304	0.00483	CcSEcCtD
Tiludronate—Asthenia—Bimatoprost—glaucoma	0.00303	0.00481	CcSEcCtD
Tiludronate—Pain—Brinzolamide—glaucoma	0.003	0.00477	CcSEcCtD
Tiludronate—Diarrhoea—Apraclonidine—glaucoma	0.00298	0.00473	CcSEcCtD
Tiludronate—Dyspepsia—Pilocarpine—glaucoma	0.00297	0.00472	CcSEcCtD
Tiludronate—Gastrointestinal pain—Dorzolamide—glaucoma	0.00292	0.00464	CcSEcCtD
Tiludronate—Gastrointestinal pain—Travoprost—glaucoma	0.00291	0.00462	CcSEcCtD
Tiludronate—Pain—Pilocarpine—glaucoma	0.00289	0.00458	CcSEcCtD
Tiludronate—Dizziness—Apraclonidine—glaucoma	0.00288	0.00457	CcSEcCtD
Tiludronate—Abdominal pain—Dorzolamide—glaucoma	0.00282	0.00448	CcSEcCtD
Tiludronate—Arthralgia—Clonidine—glaucoma	0.00281	0.00446	CcSEcCtD
Tiludronate—Abdominal pain—Travoprost—glaucoma	0.00281	0.00446	CcSEcCtD
Tiludronate—Asthenia—Acetazolamide—glaucoma	0.0028	0.00444	CcSEcCtD
Tiludronate—Dizziness—Bimatoprost—glaucoma	0.00279	0.00444	CcSEcCtD
Tiludronate—Gastrointestinal pain—Pilocarpine—glaucoma	0.00276	0.00438	CcSEcCtD
Tiludronate—Headache—Apraclonidine—glaucoma	0.00273	0.00433	CcSEcCtD
Tiludronate—Rhinitis—Timolol—glaucoma	0.00271	0.0043	CcSEcCtD
Tiludronate—Asthenia—Brimonidine—glaucoma	0.00268	0.00426	CcSEcCtD
Tiludronate—Abdominal pain—Pilocarpine—glaucoma	0.00267	0.00424	CcSEcCtD
Tiludronate—Diarrhoea—Acetazolamide—glaucoma	0.00267	0.00423	CcSEcCtD
Tiludronate—Headache—Bimatoprost—glaucoma	0.00265	0.0042	CcSEcCtD
Tiludronate—Nausea—Apraclonidine—glaucoma	0.00259	0.00411	CcSEcCtD
Tiludronate—Vertigo—Betaxolol—glaucoma	0.00258	0.0041	CcSEcCtD
Tiludronate—Dizziness—Acetazolamide—glaucoma	0.00258	0.00409	CcSEcCtD
Tiludronate—Asthenia—Dorzolamide—glaucoma	0.00256	0.00407	CcSEcCtD
Tiludronate—Asthenia—Travoprost—glaucoma	0.00255	0.00405	CcSEcCtD
Tiludronate—Asthenia—Brinzolamide—glaucoma	0.00252	0.004	CcSEcCtD
Tiludronate—Nausea—Bimatoprost—glaucoma	0.00251	0.00398	CcSEcCtD
Tiludronate—Dizziness—Brimonidine—glaucoma	0.00247	0.00393	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Clonidine—glaucoma	0.00246	0.0039	CcSEcCtD
Tiludronate—Arthralgia—Betaxolol—glaucoma	0.00245	0.00389	CcSEcCtD
Tiludronate—Myalgia—Betaxolol—glaucoma	0.00245	0.00389	CcSEcCtD
Tiludronate—Diarrhoea—Dorzolamide—glaucoma	0.00244	0.00388	CcSEcCtD
Tiludronate—Headache—Acetazolamide—glaucoma	0.00244	0.00388	CcSEcCtD
Tiludronate—Diarrhoea—Travoprost—glaucoma	0.00243	0.00386	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—LRP12—glaucoma	0.00243	0.00712	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LRP12—glaucoma	0.00243	0.00712	CbGpPWpGaD
Tiludronate—Asthenia—Pilocarpine—glaucoma	0.00242	0.00385	CcSEcCtD
Tiludronate—Diarrhoea—Brinzolamide—glaucoma	0.0024	0.00382	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1A—glaucoma	0.00237	0.00696	CbGpPWpGaD
Tiludronate—Dizziness—Dorzolamide—glaucoma	0.00236	0.00375	CcSEcCtD
Tiludronate—Dizziness—Travoprost—glaucoma	0.00235	0.00373	CcSEcCtD
Tiludronate—Headache—Brimonidine—glaucoma	0.00234	0.00372	CcSEcCtD
Tiludronate—PTPN1—Immune System—CTSA—glaucoma	0.00234	0.00688	CbGpPWpGaD
Tiludronate—Dizziness—Brinzolamide—glaucoma	0.00232	0.00369	CcSEcCtD
Tiludronate—Nausea—Acetazolamide—glaucoma	0.00232	0.00368	CcSEcCtD
Tiludronate—Diarrhoea—Pilocarpine—glaucoma	0.00231	0.00367	CcSEcCtD
Tiludronate—Pain—Clonidine—glaucoma	0.00231	0.00366	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00229	0.00673	CbGpPWpGaD
Tiludronate—Headache—Dorzolamide—glaucoma	0.00224	0.00355	CcSEcCtD
Tiludronate—Dizziness—Pilocarpine—glaucoma	0.00223	0.00354	CcSEcCtD
Tiludronate—ATP6V1A—Disease—FGFR1OP—glaucoma	0.00223	0.00655	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HEYL—glaucoma	0.00223	0.00655	CbGpPWpGaD
Tiludronate—Headache—Travoprost—glaucoma	0.00223	0.00354	CcSEcCtD
Tiludronate—Nausea—Brimonidine—glaucoma	0.00222	0.00353	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—FN1—glaucoma	0.00221	0.00649	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Clonidine—glaucoma	0.0022	0.0035	CcSEcCtD
Tiludronate—Headache—Brinzolamide—glaucoma	0.0022	0.00349	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—TGFB2—glaucoma	0.00216	0.00634	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00214	0.00339	CcSEcCtD
Tiludronate—Abdominal pain—Clonidine—glaucoma	0.00213	0.00338	CcSEcCtD
Tiludronate—Nausea—Dorzolamide—glaucoma	0.00212	0.00337	CcSEcCtD
Tiludronate—Headache—Pilocarpine—glaucoma	0.00211	0.00336	CcSEcCtD
Tiludronate—Nausea—Travoprost—glaucoma	0.00211	0.00335	CcSEcCtD
Tiludronate—Vertigo—Timolol—glaucoma	0.00211	0.00335	CcSEcCtD
Tiludronate—Nausea—Brinzolamide—glaucoma	0.00209	0.00331	CcSEcCtD
Tiludronate—Dyspepsia—Betaxolol—glaucoma	0.00207	0.00328	CcSEcCtD
Tiludronate—Pain—Betaxolol—glaucoma	0.00201	0.00319	CcSEcCtD
Tiludronate—Nausea—Pilocarpine—glaucoma	0.00201	0.00318	CcSEcCtD
Tiludronate—Myalgia—Timolol—glaucoma	0.002	0.00318	CcSEcCtD
Tiludronate—Arthralgia—Timolol—glaucoma	0.002	0.00318	CcSEcCtD
Tiludronate—PTPN1—Immune System—TXNIP—glaucoma	0.00197	0.00579	CbGpPWpGaD
Tiludronate—Asthenia—Clonidine—glaucoma	0.00193	0.00307	CcSEcCtD
Tiludronate—PTPN1—Immune System—TBK1—glaucoma	0.00193	0.00568	CbGpPWpGaD
Tiludronate—Diarrhoea—Clonidine—glaucoma	0.00184	0.00293	CcSEcCtD
Tiludronate—Dizziness—Clonidine—glaucoma	0.00178	0.00283	CcSEcCtD
Tiludronate—PTPN1—Immune System—C1QB—glaucoma	0.00175	0.00513	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Timolol—glaucoma	0.00175	0.00277	CcSEcCtD
Tiludronate—Headache—Clonidine—glaucoma	0.00169	0.00268	CcSEcCtD
Tiludronate—Dyspepsia—Timolol—glaucoma	0.00169	0.00268	CcSEcCtD
Tiludronate—Asthenia—Betaxolol—glaucoma	0.00168	0.00267	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—OPN4—glaucoma	0.00168	0.00494	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—OPN4—glaucoma	0.00168	0.00494	CbGpPWpGaD
Tiludronate—Pain—Timolol—glaucoma	0.00164	0.0026	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—SOD1—glaucoma	0.00164	0.0048	CbGpPWpGaD
Tiludronate—Diarrhoea—Betaxolol—glaucoma	0.00161	0.00255	CcSEcCtD
Tiludronate—Nausea—Clonidine—glaucoma	0.0016	0.00254	CcSEcCtD
Tiludronate—Gastrointestinal pain—Timolol—glaucoma	0.00157	0.00249	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—HEYL—glaucoma	0.00156	0.00459	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HEYL—glaucoma	0.00156	0.00459	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TXN—glaucoma	0.00156	0.00457	CbGpPWpGaD
Tiludronate—Dizziness—Betaxolol—glaucoma	0.00155	0.00246	CcSEcCtD
Tiludronate—Abdominal pain—Timolol—glaucoma	0.00152	0.00241	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—PTGFR—glaucoma	0.00151	0.00445	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTGFR—glaucoma	0.00151	0.00445	CbGpPWpGaD
Tiludronate—Headache—Betaxolol—glaucoma	0.00147	0.00233	CcSEcCtD
Tiludronate—Nausea—Betaxolol—glaucoma	0.00139	0.00221	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HDAC9—glaucoma	0.00139	0.00409	CbGpPWpGaD
Tiludronate—Asthenia—Timolol—glaucoma	0.00138	0.00218	CcSEcCtD
Tiludronate—Diarrhoea—Timolol—glaucoma	0.00131	0.00208	CcSEcCtD
Tiludronate—Dizziness—Timolol—glaucoma	0.00127	0.00201	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.00126	0.00371	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MMP1—glaucoma	0.00125	0.00366	CbGpPWpGaD
Tiludronate—Headache—Timolol—glaucoma	0.0012	0.00191	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—CAV1—glaucoma	0.0012	0.00351	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RPTOR—glaucoma	0.00118	0.00348	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RPTOR—glaucoma	0.00118	0.00348	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NCK2—glaucoma	0.00115	0.00337	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NCK2—glaucoma	0.00115	0.00337	CbGpPWpGaD
Tiludronate—Nausea—Timolol—glaucoma	0.00114	0.00181	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—FN1—glaucoma	0.00114	0.00334	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HDAC9—glaucoma	0.000975	0.00286	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HDAC9—glaucoma	0.000975	0.00286	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS3—glaucoma	0.000904	0.00266	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1A—glaucoma	0.000774	0.00227	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SMO—glaucoma	0.000763	0.00224	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SMO—glaucoma	0.000763	0.00224	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN2B—glaucoma	0.000749	0.0022	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NTRK2—glaucoma	0.000698	0.00205	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NTRK2—glaucoma	0.000698	0.00205	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—C3—glaucoma	0.00068	0.002	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—glaucoma	0.000652	0.00191	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—glaucoma	0.000651	0.00191	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—glaucoma	0.000628	0.00184	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NGFR—glaucoma	0.000599	0.00176	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NGFR—glaucoma	0.000599	0.00176	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BAD—glaucoma	0.00059	0.00173	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOE—glaucoma	0.000584	0.00172	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CAV1—glaucoma	0.000579	0.0017	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NTRK1—glaucoma	0.000569	0.00167	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NTRK1—glaucoma	0.000569	0.00167	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BAD—glaucoma	0.000545	0.0016	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN2B—glaucoma	0.000524	0.00154	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN2B—glaucoma	0.000524	0.00154	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDN1—glaucoma	0.000503	0.00148	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDN1—glaucoma	0.000503	0.00148	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—glaucoma	0.000492	0.00145	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NGF—glaucoma	0.000462	0.00136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NGF—glaucoma	0.000462	0.00136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—C3—glaucoma	0.00044	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—C3—glaucoma	0.00044	0.00129	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—glaucoma	0.000438	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—glaucoma	0.000411	0.00121	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—glaucoma	0.000409	0.0012	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—glaucoma	0.000409	0.0012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CAV1—glaucoma	0.000405	0.00119	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CAV1—glaucoma	0.000405	0.00119	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—glaucoma	0.0004	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FN1—glaucoma	0.000386	0.00113	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FN1—glaucoma	0.000386	0.00113	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BAD—glaucoma	0.000381	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BAD—glaucoma	0.000381	0.00112	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—glaucoma	0.000379	0.00111	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—glaucoma	0.000307	0.0009	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—glaucoma	0.000307	0.0009	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—glaucoma	0.000266	0.00078	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—glaucoma	0.000266	0.00078	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—glaucoma	0.000246	0.000722	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—glaucoma	0.000246	0.000722	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—glaucoma	0.000221	0.000649	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—glaucoma	0.000221	0.000649	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—glaucoma	0.000167	0.00049	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—glaucoma	0.000167	0.00049	CbGpPWpGaD
